SG3 Management, LLC - TRILLIUM THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
SG3 Management, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$351,000
+80.9%
20,0000.0%0.01%
+57.1%
Q2 2021$194,000
-63.9%
20,000
-60.0%
0.01%
-46.2%
Q1 2021$537,000
-86.9%
50,000
-82.0%
0.01%
-83.3%
Q4 2020$4,086,000–277,800–0.08%–
 Download
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders